|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang X, Lu H, Urvalek AM, Li T, Yu L,
Lamar J, DiPersio CM, Feustel PJ and Zhao J: KLF8 promotes human
breast cancer cell invasion and metastasis by transcriptional
activation of MMP9. Oncogene. 30:1901–1911. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang G, Liu Z, Xu H and Yang Q:
miR-409-3p suppresses breast cancer cell growth and invasion by
targeting Akt1. Biochem Biophys Res Commun. 469:189–195. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen CP, Sun ZL, Lu X, Wu WX, Guo WL, Lu
JJ, Han C, Huang JQ and Fang Y: MiR-340 suppresses cell migration
and invasion by targeting MYO10 in breast cancer. Oncol Rep.
35:709–716. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang C, Zhang Y, Ding W, Lin Y, Huang Z
and Luo Q: MiR-33a suppresses breast cancer cell proliferation and
metastasis by targeting ADAM9 and ROS1. Protein Cell. 6:881–889.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song C, Liu LZ, Pei XQ, Liu X, Yang L, Ye
F and Xie X, Chen J, Tang H and Xie X: miR-200c inhibits breast
cancer proliferation by targeting KRAS. Oncotarget. 6:34968–34978.
2015.PubMed/NCBI
|
|
7
|
Yan L, Yu J, Tan F, Ye GT, Shen ZY, Liu H,
Zhang Y, Wang JF, Zhu XJ and Li GX: SP1-mediated microRNA-520d-5p
suppresses tumor growth and metastasis in colorectal cancer by
targeting CTHRC1. Am J Cancer Res. 5:1447–1459. 2015.PubMed/NCBI
|
|
8
|
Freund A, Chauveau C, Brouillet JP, Lucas
A, Lacroix M, Licznar A, Vignon F and Lazennec G: IL-8 expression
and its possible relationship with estrogen-receptor-negative
status of breast cancer cells. Oncogene. 22:256–265. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu YM, Webster SJ, Flower D and Woll PJ:
Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
Br J Cancer. 91:1970–1976. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Seaton A, Scullin P, Maxwell PJ, Wilson C,
Pettigrew J, Gallagher R, O'Sullivan JM, Johnston PG and Waugh DJ:
Interleukin-8 signaling promotes androgen-independent proliferation
of prostate cancer cells via induction of androgen receptor
expression and activation. Carcinogenesis. 29:1148–1156. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Xu RC, Zhang XL, Niu XL, Qu Y, Li
LZ and Meng XY: Interleukin-8 secretion by ovarian cancer cells
increases anchorage-independent growth, proliferation, angiogenic
potential, adhesion and invasion. Cytokine. 59:145–155. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim JH, Frantz AM, Anderson KL, Graef AJ,
Scott MC, Robinson S, Sharkey LC, O'Brien TD, Dickerson EB and
Modiano JF: Interleukin-8 promotes canine hemangiosarcoma growth by
regulating the tumor microenvironment. Exp Cell Res. 323:155–164.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sanmamed MF, Carranza-Rua O, Alfaro C,
Oñate C, Martín-Algarra S, Perez G, Landazuri SF, Gonzalez A, Gross
S, Rodriguez I, et al: Serum interleukin-8 reflects tumor burden
and treatment response across malignancies of multiple tissue
origins. Clin Cancer Res. 20:5697–5707. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Y, Shi M, Yu GZ, Qin XR, Jin G, Chen
P and Zhu MH: Interleukin-8, a promising predictor for prognosis of
pancreatic cancer. World J Gastroenterol. 18:1123–1129. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chi N, Tan Z, Ma K, Bao L and Yun Z:
Increased circulating myeloid-derived suppressor cells correlate
with cancer stages, interleukin-8 and −6 in prostate cancer. Int J
Clin Exp Med. 7:3181–3192. 2014.PubMed/NCBI
|
|
16
|
Todorović-Raković N and Milovanović J:
Interleukin-8 in breast cancer progression. J Interferon Cytokine
Res. 33:563–570. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fernando RI, Castillo MD, Litzinger M,
Hamilton DH and Palena C: IL-8 signaling plays a critical role in
the epithelial-mesenchymal transition of human carcinoma cells.
Cancer Res. 71:5296–5306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Balhana R, Stoker NG, Sikder MH, Chauviac
FX and Kendall SL: Rapid construction of mycobacterial mutagenesis
vectors using ligation-independent cloning. J Microbiol Methods.
83:34–41. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bryksin AV and Matsumura I: Overlap
extension PCR cloning: A simple and reliable way to create
recombinant plasmids. Biotechniques. 48:463–465. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun H, Li QW, Lv XY, Ai JZ, Yang QT, Duan
JJ, Bian GH, Xiao Y, Wang YD, Zhang Z, et al: MicroRNA-17
post-transcriptionally regulates polycystic kidney disease-2 gene
and promotes cell proliferation. Mol Biol Rep. 37:2951–2958. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang N, Wei L, Huang Y, Wu Y, Su M, Pang
X, Wang N, Ji F, Zhong C, Chen T, et al: miR520c blocks EMT
progression of human breast cancer cells by repressing STAT3. Oncol
Rep. 37:1537–1544. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
lyu Z, Mao Z, Wang H, Fang Y, Chen T, Wan
Q, Wang M, Wang N, Xiao J, Wei H, et al: MiR-181b targets Six2 and
inhibits the proliferation of metanephric mesenchymal cells in
vitro. Biochem Biophys Res Commun. 440:495–501. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kucuksayan H, Ozes ON and Akca H:
Downregulation of SATB2 is critical for induction of
epithelial-to-mesenchymal transition and invasion of NSCLC cells.
Lung Cancer. 98:122–129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
da Cunha IW, Souza MJ, da Costa WH,
Amâncio AM, Fonseca FP, Zequi SC, Lopes A, Guimarães GC and Soares
F: Epithelial-mesenchymal transition (EMT) phenotype at invasion
front of squamous cell carcinoma of the penis influences
oncological outcomes. Urol Oncol. 34:433.e19–433.e26. 2016.
View Article : Google Scholar
|
|
27
|
Musolino C, Allegra A, Pioggia G and
Gangemi S: Immature myeloid-derived suppressor cells: A bridge
between inflammation and cancer (Review). Oncol Rep. 37:671–683.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Coffelt SB and de Visser KE: Cancer:
Inflammation lights the way to metastasis. Nature. 507:48–49. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Roshani R, McCarthy F and Hagemann T:
Inflammatory cytokines in human pancreatic cancer. Cancer Lett.
345:157–163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee YS, Choi I, Ning Y, Kim NY,
Khatchadourian V, Yang D, Chung HK, Choi D, LaBonte MJ, Ladner RD,
et al: Interleukin-8 and its receptor CXCR2 in the tumour
microenvironment promote colon cancer growth, progression and
metastasis. Br J Cancer. 106:1833–1841. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reis ST, Leite KR, Piovesan LF,
Pontes-Junior J, Viana NI, Abe DK, Crippa A, Moura CM, Adonias SP,
Srougi M, et al: Increased expression of MMP-9 and IL-8 are
correlated with poor prognosis of bladder cancer. BMC Urol.
12:182012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Y, Rong G and Kang H: Taxotere-induced
elevated expression of IL8 in carcinoma-associated fibroblasts of
breast invasive ductal cancer. Oncol Lett. 13:1856–1860.
2017.PubMed/NCBI
|
